Professor Gregory Monteith
Professor

Gregory Monteith

Email: 
Phone: 
+61 7 334 61855

Background

Greg studies cellular signalling in disease and the identification of new drug targets. Greg leads the Calcium Signalling Therapeutics Team (CaSTT) in the School of Pharmacy at UQ.

His lab specializes in the development and application of genetically encoded calcium indicators for high-content imaging in live cells. His team focuses on integrating these technologies into high-throughput assays that are critical for drug discovery efforts targeting calcium-mediated signaling pathways. The group has developed and utilized high-content imaging platforms to investigate calcium signaling in various cell types. These platforms enable the team to conduct large-scale screenings and these have been instrumental in identifying novel therapeutic targets.

Greg has established a research program with research funding via NHMRC, ARC, Queensland Cancer Council, Society of Biomolecular Screening, Department of Defense (USA) and other grants and collaboration with Pharmaceutical companies. His interests are signal transduction in disease, calcium transporters as drug targets and biomolecular screening. His work has led to patents and projects towards commercialization for new therapies for cancer.

In 2006 he received a UQ Foundation research excellence award and in 2016 he received the UQ Research Higher Degree Supervision Excellence Award - video link. Greg has also recieved a Research Mentorship Award (HaBS, 2017) and an award for Excellence in Leadership (UQ, 2016).

Availability

Professor Gregory Monteith is:
Available for supervision

Fields of research

Biological Sciences Oncology and carcinogenesis Pharmacology and pharmaceutical sciences

Qualifications

  • Bachelor (Honours), University of Sydney
  • Doctor of Philosophy, University of Sydney

Research interests

  • calcium regulation in disease and cell signalling

    Our current projects are focussed on the study of a variety of calcium transporters in disease for the identification of novel drug targets. PhD and Post-doctoral opportunities may be available, contact - gregm@uq.edu.au and see the "available projects" link.

  • High throughput calcium assays for biomolecular screening and cancer research

    Our laboratory has the the first FLIPR-tetra system in Australia, allowing high throughput measurement of intracellular calcium in living cells.

Search Professor Gregory Monteith’s works on UQ eSpace

419 works between 1992 and 2024
All (419) Journal Article (138) Book Chapter (7) Conference Publication (273) Book (1)

321 - 340 of 419 works

2005

Conference Publication

High throughput calcium assays: From discovery to understanding

Monteith, G. R. (2005). High throughput calcium assays: From discovery to understanding. Joint Meeting of ASCEPT and APSA, Melbourne, Vic, Australia, 4-7 December, 2005. Melbourne, Vic, Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.

High throughput calcium assays: From discovery to understanding

2005

Conference Publication

Blockade of relapse with pioglitazone in a multiple relapsing-remitting experimental autoimmune encephalomyelitis in C57BL/6 mice

Peiris, M., Roberts-Thomson, S. J., Monteith, G. R. and Cabot, P. J. (2005). Blockade of relapse with pioglitazone in a multiple relapsing-remitting experimental autoimmune encephalomyelitis in C57BL/6 mice. 5th Annual Health & Medical Research Conference of Queensland, Brisbane, Qld, Australia, 3-4 November, 2005. Brisbane, Qld, Australia: Queensland Health.

Blockade of relapse with pioglitazone in a multiple relapsing-remitting experimental autoimmune encephalomyelitis in C57BL/6 mice

2005

Conference Publication

Consumers on the map: Australia's QUM map

Tett, S. E., Roughead, E. E., Monteith, G. R. and Kirkpatrick, C. M. J. (2005). Consumers on the map: Australia's QUM map. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, Qld, Australia, 10-13 November, 2005. Brisbane, Qld, Australia: Event Planners Australia.

Consumers on the map: Australia's QUM map

2005

Conference Publication

Expression of plasma membrane calcium pump isoforms in a colon cancer cell line

Aung, C. S., Roberts-Thomson, S. J. and Monteith, G. R. (2005). Expression of plasma membrane calcium pump isoforms in a colon cancer cell line. Joint Meeting of ASCEPT and APSA, Melbourne, Vic, Australia, 4-7 December, 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.

Expression of plasma membrane calcium pump isoforms in a colon cancer cell line

2005

Conference Publication

Anti-proliferative effects of novel glyco-lipoaminoacid-modified arsenicals (III) on MCF-7 human breast cancer cells

Wimmer, N., Robinson, J. A., Thomson, S. J., Monteith, G. R. and Toth, I. (2005). Anti-proliferative effects of novel glyco-lipoaminoacid-modified arsenicals (III) on MCF-7 human breast cancer cells. 19th American Peptide Symposium, San Diego, U.S., 18-23 June, 2005. Hoboken, U.S.: Wiley Interscience.

Anti-proliferative effects of novel glyco-lipoaminoacid-modified arsenicals (III) on MCF-7 human breast cancer cells

2005

Journal Article

Antisense-mediated inhibition of the plasma membrane Calcium-ATPase suppresses proliferation of MCF-7 cells

Lee, W. J., Robinson, J. A., Holman, N. A., McCall, M. N., Roberts-Thomson, S. J. and Monteith, G. R. (2005). Antisense-mediated inhibition of the plasma membrane Calcium-ATPase suppresses proliferation of MCF-7 cells. Journal of Biological Chemistry, 280 (29), 27076-27084. doi: 10.1074/jbc.M414142200

Antisense-mediated inhibition of the plasma membrane Calcium-ATPase suppresses proliferation of MCF-7 cells

2005

Conference Publication

Opioid inhibition of TRPV1-mediated calcium currents in cultured dorsal root ganglion neurones and a HEK293 cell line stably expressing TRPV1 and MOR

Vetter, I., Wyse, B. D., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2005). Opioid inhibition of TRPV1-mediated calcium currents in cultured dorsal root ganglion neurones and a HEK293 cell line stably expressing TRPV1 and MOR. 11th World Congress on Pain, Sydney, NSW, Australia, 21-26 August, 2005. Seattle, WA, U.S.A.: International Association for the Study of Pain (IASP) Press.

Opioid inhibition of TRPV1-mediated calcium currents in cultured dorsal root ganglion neurones and a HEK293 cell line stably expressing TRPV1 and MOR

2005

Conference Publication

Peroxisome proliferator activated receptor (PPAR) isoform expression during differentiation of HT-29 colon cancer cells

Lister, E. J., Faddy, H. M., Aung, C. S., Monteith, G. R. and Roberts-Thomson, S. J. (2005). Peroxisome proliferator activated receptor (PPAR) isoform expression during differentiation of HT-29 colon cancer cells. Joint Meeting of ASCEPT and APSA, Melbourne, Vic, Australia, 4-7 December, 2005. Melbourne, Vic, Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.

Peroxisome proliferator activated receptor (PPAR) isoform expression during differentiation of HT-29 colon cancer cells

2005

Conference Publication

Development and application of a liposome delivery method to enhance the bioavailability of antioxidants and evaluate cytotoxicity in colon and breast cancer in vitro models

Sutherland, A., Hewavitharana, A., Flanagan, B. M., Monteith, G. R., Shaw, N., Roberts-Thomson, S. J. and Gidley, M. (2005). Development and application of a liposome delivery method to enhance the bioavailability of antioxidants and evaluate cytotoxicity in colon and breast cancer in vitro models. 29th Annual Scientific Meeting of Nutrition Society of Australia, Melbourne, Vic, Australia, 30 November-3 December, 2005. Clayton, Vic., Australia: Blackwell Science Asia.

Development and application of a liposome delivery method to enhance the bioavailability of antioxidants and evaluate cytotoxicity in colon and breast cancer in vitro models

2005

Journal Article

Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines

Lee, WJ, Roberts-Thomson, SJ and Monteith, GR (2005). Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines. Biochemical And Biophysical Research Communications, 337 (3), 779-783. doi: 10.1016/j.bbrc.2005.09.119

Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines

2005

Conference Publication

Pioglitazone treatment prevents relapse in a multiple relapsing-remitting experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice

Peiris, M., Roberts-Thomson, S. J., Monteith, G. R. and Cabot, P. J. (2005). Pioglitazone treatment prevents relapse in a multiple relapsing-remitting experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice. Joint Meeting of ASCEPT and APSA, Melbourne, Vic, Australia, 4-7 December, 2005. Melbourne, Vic, Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists.

Pioglitazone treatment prevents relapse in a multiple relapsing-remitting experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice

2004

Journal Article

Effect of the peroxisome proliferator-activated receptor beta activator GW0742 in rat cultured cerebellar granule neurons

Smith, Steven A., Monteith, Gregory R., Robinson, Jodie A., Gopisetty Venkata, Nagaraj, May, Fiona J. and Roberts-Thomson, Sarah J. (2004). Effect of the peroxisome proliferator-activated receptor beta activator GW0742 in rat cultured cerebellar granule neurons. Journal of Neuroscience Research, 77 (2), 240-249. doi: 10.1002/jnr.20153

Effect of the peroxisome proliferator-activated receptor beta activator GW0742 in rat cultured cerebellar granule neurons

2004

Conference Publication

A novel multiple relapsing model of multiple sclerosis: Experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice

Roberts-Thomson, S. J., Peiris, M., Monteith, G. R. and Cabot, P. J. (2004). A novel multiple relapsing model of multiple sclerosis: Experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice. Melbourne Regional Meeting of ASCEPT, Melbourne University, 30 November, 2004. Melbourne, Vic, Australia: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT).

A novel multiple relapsing model of multiple sclerosis: Experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice

2004

Conference Publication

Beta -endorphin inhibition of capsaicin induced calcium responses in cultured dorsal root ganglion neurones is enhanced at acidic pH's

Vetter, I., Hermanussen, S. F., Monteith, G. R. and Cabot, P. J. (2004). Beta -endorphin inhibition of capsaicin induced calcium responses in cultured dorsal root ganglion neurones is enhanced at acidic pH's. CPT2004: 8th World Conference on Clinical Pharmacology & Therapeutics 2004, Brisbane, Qld, Australia, 1-6 August, 2004. Melbourne, Vic, Australia: Blackwell Publishing.

Beta -endorphin inhibition of capsaicin induced calcium responses in cultured dorsal root ganglion neurones is enhanced at acidic pH's

2004

Conference Publication

Fluorescence probes for the assessment of calcium in sub-cellular organelles: Implications for microplate readers

Monteith, G. R., Robinson, J. A., Jenkins, N. and Roberts-Thomson, S. J. (2004). Fluorescence probes for the assessment of calcium in sub-cellular organelles: Implications for microplate readers. SBS 10th Anniversary Conference and Exhibition, Orlando, Florida, U.S.A., 11-15 September, 2004. Florida, U.S.A.: Society for Biomolecular Screening.

Fluorescence probes for the assessment of calcium in sub-cellular organelles: Implications for microplate readers

2004

Conference Publication

Phthalates: A possible peroxisome proliferator-activated receptor mediated effect in breast cancer cell lines

Gopisetty Venkata, N., Robinson, J. A., Davis, B.J., Monteith, G. R. and Roberts-Thomson, S. J. (2004). Phthalates: A possible peroxisome proliferator-activated receptor mediated effect in breast cancer cell lines. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, 30 Nov - 1 Dec 2004. Brisbane: Qld. Government.

Phthalates: A possible peroxisome proliferator-activated receptor mediated effect in breast cancer cell lines

2004

Conference Publication

Assessment of the expression of a calcium transporter in cancer cells exposed to conditions which promote differentiation

Aung, C. S., Lee, W. J., Huynh, H., Tran, K. M., Robinson, J. A., Faddy, H. M., Gopisetty Venkata, N., Roberts-Thomson, S. J. and Monteith, G. R. (2004). Assessment of the expression of a calcium transporter in cancer cells exposed to conditions which promote differentiation. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, 30 November - 1 December 2004. Brisbane: Qld Government.

Assessment of the expression of a calcium transporter in cancer cells exposed to conditions which promote differentiation

2004

Journal Article

Ratiometric and nonratiometric Ca2+ indicators for the assessment of intracellular free Ca2+ in a breast cancer cell line using a fluorescence microplate reader

Robinson, J. A., Jenkins, N. S., Holman, N. A., Roberts-Thomson, S. J. and Monteith, G. R. (2004). Ratiometric and nonratiometric Ca2+ indicators for the assessment of intracellular free Ca2+ in a breast cancer cell line using a fluorescence microplate reader. Journal of Biochemical And Biophysical Methods, 58 (3), 227-237. doi: 10.1016/j.jbbm.2003.11.002

Ratiometric and nonratiometric Ca2+ indicators for the assessment of intracellular free Ca2+ in a breast cancer cell line using a fluorescence microplate reader

2004

Conference Publication

Peroxisome proliferator-activated receptor a in human breast cancer cell lines

Faddy, H. M., Robinson, J. A., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2004). Peroxisome proliferator-activated receptor a in human breast cancer cell lines. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, 30 November - 1 December, 2004. Brisbane: Qld Government.

Peroxisome proliferator-activated receptor a in human breast cancer cell lines

2004

Conference Publication

Phthalate ester toxicity in the human breast: A possible role of peroxisome proliferator-activated receptors A,b/d and g

Gopisetty Venkata, N., Robinson, J. A., Davis, B.J., Monteith, G. R. and Roberts-Thomson, S. J. (2004). Phthalate ester toxicity in the human breast: A possible role of peroxisome proliferator-activated receptors A,b/d and g. CPT2004: 8th World Conference on Clinical Pharmacology & Therapeutics, Brisbane, Qld, Australia, 1-6 Aug 2004. Melbourne, Vic, Australia: Blackwell Publishing.

Phthalate ester toxicity in the human breast: A possible role of peroxisome proliferator-activated receptors A,b/d and g

Current funding

  • 2025 - 2028
    A First-in-Class Calcium Channel Inhibitor for the Treatment of Advanced Metastatic Prostate Cancers Resistant to Next-Generation Antiandrogen Therapy
    United States Congressionally Directed Medical Research Programs - Prostate Cancer Research Program
    Open grant
  • 2023 - 2026
    A calcium influx pathway regulates adaptive cancer drug tolerance
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2023 - 2024
    A calcium influx pathway regulates adaptive cancer drug tolerance
    TdC Pioneering Grant
    Open grant
  • 2022 - 2025
    An active ion transport pathway exploited by coronaviruses
    ARC Discovery Projects
    Open grant
  • 2020 - 2024
    Deciphering and intercepting messages between cancer cells and cells in the breast cancer microenvironment: Roles for intracellular calcium signaling
    United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
    Open grant
  • 2020 - 2023
    A recently identified calcium channel provides diverse opportunities for pharmacotherapy in breast cancer
    NHMRC IDEAS Grants
    Open grant
  • 2019 - 2021
    Exploiting remodelling of calcium signalling to specifically target triple negative breast cancer via promotion of apoptosis
    Cancer Council Queensland
    Open grant
  • 2018 - 2024
    Australian Red Cross Blood Service Chair in Donor Behaviour
    Australian Red Cross Blood Service
    Open grant
  • 2018 - 2021
    Calcium cycling and heat generation in skeletal muscle fibres
    ARC Discovery Projects
    Open grant
  • 2018
    High-throughput ion channel pharmacology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2020
    Pharmacological targeting of an adaptive breast cancer cell survival pathway as a novel treatment for breast cancer: Constitutive Ca2+ influx mechanisms in triple negative breast cancer cells
    Cancer Council Queensland
    Open grant
  • 2017 - 2021
    Exploiting the Remodeling of Ca2+ Signaling in Breast Cancer Cell Microenvironments to Control Metastasis and to Specifically Target Brain Metastases
    United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
    Open grant
  • 2015 - 2021
    Collaborative Grants between WMHHS and University of Queensland
    West Moreton Hospital and Health Service
    Open grant
  • 2015 - 2017
    Exploiting the overexpression of a specific calcium permeable ion channel in breast cancer cells: a new pharmacological approach to targeting breast cancer.
    NHMRC Project Grant
    Open grant
  • 2015 - 2018
    Resistance to Herceptin (trastuzumab) in HER2 positive breast cancers: the role of calcium signalling
    NHMRC Project Grant
    Open grant
  • 2015
    The assessment of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells to identify and characterize new therapeutic targets for diseases
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014
    A medium-throughput cell isolation and analysis suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2014
    QUE ORAI1 PROJECT
    Cancer Bequest Fund
    Open grant
  • 2013 - 2014
    Identification and characterisation of calcium signalling modifying proteins as drug targets for basal breast cancer
    Cancer Council Queensland
    Open grant
  • 2012 - 2015
    Calcium signaling and epithelial-mesenchymal transition: a new approach to identifying pharmacological targets for metastasis
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    The development of store operated calcium channel monoclonal antibody inhibitors as a therapeutic option for breast cancer treatment
    NHMRC Development Grant
    Open grant
  • 2011
    Establishment of a robotic liquid handling platofrm for the use of 384 and 1536 well plates
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Cost effective acquisition of an LC-MS/MS system to support CIPDD organics analysis and preclinical and clinical operations
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    High content imaging analysis for bioactive and novel therapeutic target evaluation
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2013
    Two recently identified calcium transporters in lactation and during mammary epithelial cell apoptosis.
    NHMRC Project Grant
    Open grant
  • 2009 - 2011
    QUMmap and website
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2009 - 2010
    Multiphoton microscopy of living animals as a tool for immunology and cell biology studies
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2009
    A core pharmacy facility for molecular biology, expression and protein post translational modification studies in cancer, cardiovascular, pain and epilepsy research
    UQ School/Centre Co-Funding
    Open grant
  • 2009 - 2012
    Calcium Influx Pathways and Breast Cancer
    NHMRC Project Grant
    Open grant
  • 2009
    Robotics Instrumentation for High Throughput Sample preparation for Increased Productivity of the CIPDD/TetraQ's HPLC-MS/MS Systems for Quantitative Analysis of Organics in a Quality Systems NATA-Acc
    UQ Faculty Co-Funding
    Open grant
  • 2009 - 2011
    Secretory pathway calcium regulation and breast cancer
    Cancer Council Queensland
    Open grant
  • 2008 - 2011
    Nutritional properties of mango fruits: linking plant genomics to cellular bioactivities
    ARC Linkage Projects
    Open grant
  • 2008 - 2010
    Partnerships in Health Research Collaborative Challenge - Pick your Partners!
    Cancer Bequest Fund
    Open grant
  • 2008 - 2009
    QUMmap and Website June 2008
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2006 - 2007
    Calcium transporters and breast cancer: exploiting the link for new pharmaceutically relevant drug targets.
    UQ Foundation Research Excellence Awards - DVC(R) Funding
    Open grant
  • 2006 - 2008
    Maintenance and Promotion of the QUMMAP
    Department of Health and Ageing
    Open grant
  • 2005 - 2008
    Identification of nutritional bioactives in tropical fruit
    ARC Linkage Projects
    Open grant
  • 2005
    Establishment of an improved model of relapsing MS and the characterisation of the role of Peroxisome Proliferator - activated receoptors alpha and beta
    Multiple Sclerosis Research Australia
    Open grant
  • 2005
    Ethanol, PPARb and Breast Cancer
    Australian Brewers' Foundation
    Open grant
  • 2005
    NHMRC_Equipment Grant = DSI Telemetry System
    NHMRC Equipment Grant
    Open grant
  • 2005
    Uncharacterized Calcium Transporters as Targets for Disease: Training of a Pharmacy Student in Drug Target Identification and Characterization
    Pharmaceutical Society of Australia
    Open grant
  • 2004 - 2005
    NHMRC_Equipment Grant_HLTH_Pharmacy
    NHMRC Equipment Grant
    Open grant
  • 2004
    PPARb In Breast Cancer: Gene Transcription And Molecular Mechanisms
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2004
    Role Of Plasma Membrane Ca Pump In High Glucose Induced Changes In Ca Signalling
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2003 - 2004
    Assessment of Ca2+ levels in subcellular organelles and the activity of Ca2+ efflux pathways using fluorescence didgital imaging techniques: Application to high throughput screening
    Society for Biomolecular Screening
    Open grant
  • 2003
    Development of high-throughput assays for the identification of novel anticancer agents.
    Pharmaceutical Society of Australia
    Open grant
  • 2003
    Malvern Zetasizer 3000HS
    NHMRC Equipment Grant
    Open grant
  • 2003
    Unprecedented Alkaloid Hybrids that Selectively Modulate Various Cancers and the Central Nervous System
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2002 - 2003
    The Maintenance and promotion of the quality use of medicines mapping project website.
    Department of Health and Ageing
    Open grant
  • 2002
    Funding for molecular biology computer software
    Brain Research Fund
    Open grant
  • 2002 - 2003
    Pharmacological investigation of the toxicological effects of high doses of systemic morphine
    Queensland Cancer Fund
    Open grant
  • 2002 - 2003
    The plasma membrane calcium ATPase (PMCA) in breast tumorigenic cells
    Queensland Cancer Fund
    Open grant
  • 2001 - 2002
    NHMRC Equipment Grant 2000
    NHMRC Equipment Grant
    Open grant
  • 2001
    A biohazard laminar flow hood for neuronal cell cultures:partial cost recovery from emergency purchase
    Brain Research Fund
    Open grant
  • 2001
    Partial funding to purchase a Biohazard II laminar flow hood.
    Pharmaceutical Society of Australia
    Open grant
  • 2001
    The plasma membrane Ca2+-ATPase (PMCA) in human mammary gland tumorigenesis
    Cancer Bequest Fund
    Open grant
  • 2000
    The regulation of mitochondrial calcium in tumorigenic and non-tumorigenic breast epithelial cells
    Pharmaceutical Society of Australia
    Open grant
  • 2000
    What are the consequences of plasma membrane calcium pump inhibition? implications for calcium homeostasis, proliferation and apoptosis.
    ARC Australian Research Council (Small grants)
    Open grant
  • 1999
    Expression of the plasma membrane calcium pump during hypoxia and ischemia
    Pharmaceutical Society of Australia
    Open grant
  • 1999
    PPAR and neurotoxicity
    Brain Research Fund
    Open grant
  • 1999 - 2001
    The plasma membrane calcium pump as a target for inhibition by tyrosine kinase phosphorylation: implications for cardiovascular disease
    National Heart Foundation of Australia
    Open grant
  • 1999
    The use of fluorescence microscopy to investigate the role of the calcium pump in disease and the mechanism of excitatory side effects by high dose morphine
    Ramaciotti Foundation
    Open grant
  • 1999
    Travel costs to neurosciences meeting 1999
    Potter Foundation
    Open grant
  • 1998
    Regulation of calcium pumps in smooth muscle
    Pharmaceutical Society of Australia
    Open grant

Availability

Professor Gregory Monteith is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Calcium signalling pathways in cancer progression

  • Calcium signalling changes associated with viral infection

  • Calcium channels and pumps as drug targets

  • Design of innovative high throughput methods for drug screening and testing

Supervision history

Current supervision

  • Doctor Philosophy

    Development of a new approach to target exosomes for cancer treatment

    Associate Advisor

    Other advisors: Dr Sherry Wu

  • Doctor Philosophy

    A Recently Identified Calcium Channel Provides Diverse Opportunities for Pharmacotherapy in Breast Cancer

    Associate Advisor

    Other advisors: Dr Ben Ross

  • Doctor Philosophy

    The intersection between calcium signaling pathways and coronavirus infection

    Associate Advisor

    Other advisors: Dr Larisa Labzin, Dr Melanie Robitaille

Completed supervision

Enquiries

For media enquiries about Professor Gregory Monteith's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au